We speculate that this decreased TSP-1 expression in ELBW infants with BPD may be susceptible to immunomodulatory drugs (IMiDs) [40] and synthetic TSP-1 mimetics [41], thereby offering additional therapeutic opportunities for BPD. This evidence concerns the gene THBS1 and bronchopulmonary dysplasia.